Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

1.3K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
1.3K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

784
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
784
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

3.6K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
3.6K
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

3.4K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.4K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

991
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
991
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

5.9K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perioperative Adverse Events in Primary Palatoplasty: "Risk Factors and Impact on Care Escalation in a Multicenter Cohort".

Paediatric anaesthesia·2026
Same author

Pediatric Anesthesia Practice and Training in Ibero-America: A Web-Based Cross-Sectional Survey.

Paediatric anaesthesia·2026
Same author

Emergence delirium prevention through electroencephalogram-guided anesthesia: a new standard for pediatric care?

Translational pediatrics·2026
Same author

Remimazolam and Emergence Delirium in Children: Encouraging Signals, Incomplete Certainty.

Paediatric anaesthesia·2026
Same author

Enhanced Recovery After Surgery (ERAS) in Latin America and the Caribbean: A Scoping Review of Implementation Strategies, Clinical Outcomes, and Health System Impact.

World journal of surgery·2026
Same author

Improving Outcome Reporting in Paediatric Airway Management in Clinical Trials (IMPACT): A Study Protocol for Core Outcomes and Clinical Endpoints.

Acta anaesthesiologica Scandinavica·2025
Same journal

Inflammatory Indices and Pediatric Emergence Delirium: Predictive Signal or Statistical Artifact?

Paediatric anaesthesia·2026
Same journal

Perspectives in Pediatric Ambulatory Anesthesia: Part 1-One Center's 15 Year Evolution in Eligibility, Utilization, Efficiency, and Outcomes.

Paediatric anaesthesia·2026
Same journal

Retrospective Evaluation of an Artificial Intelligence-Assisted Video Laryngoscope System for Tracheal Intubation in Infants and Neonates.

Paediatric anaesthesia·2026
Same journal

Perspectives in Pediatric Ambulatory Anesthesia: Part 2-One Center's 15 Year Experience Improving Quality and Safety Outcomes.

Paediatric anaesthesia·2026
Same journal

Response to: Reliability of the Pediatric Specific ASA Physical Status Classification.

Paediatric anaesthesia·2026
Same journal

Perspectives in Pediatric Ambulatory Anesthesia: Part 4-Evolving Solutions in Pediatric Ambulatory Anesthesia: From Registries to a Learning Health System Approach.

Paediatric anaesthesia·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
04:30

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

Published on: March 8, 2024

2.0K

Error Traps in Pediatric Neuromuscular Block.

Gabriel Soares de Sousa1,2,3,4, Debra Faulk5,6, Vinicius Caldeira Quintao1,2,3

  • 1Discipline of Anesthesiology, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Paediatric Anaesthesia
|April 30, 2026
PubMed
Summary
This summary is machine-generated.

Pediatric anesthesia requires careful management of neuromuscular blocking agents to prevent harm. Avoiding common errors in their use, monitoring, and reversal significantly reduces residual neuromuscular block and improves patient safety.

Keywords:
neostigmineneuromuscular blocking agentsneuromuscular monitoringpediatric anesthesiasugammadex

More Related Videos

Electrophysiological Methods to Assess Peripheral Pain Block in an Anesthetized Rat
08:05

Electrophysiological Methods to Assess Peripheral Pain Block in an Anesthetized Rat

Published on: November 21, 2025

346
Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

12.9K

Related Experiment Videos

Last Updated: May 1, 2026

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
04:30

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

Published on: March 8, 2024

2.0K
Electrophysiological Methods to Assess Peripheral Pain Block in an Anesthetized Rat
08:05

Electrophysiological Methods to Assess Peripheral Pain Block in an Anesthetized Rat

Published on: November 21, 2025

346
Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

12.9K

Area of Science:

  • Anesthesiology
  • Pediatric Pharmacology
  • Patient Safety

Background:

  • Neuromuscular blocking agents are vital in pediatric anesthesia but pose risks if misused.
  • Infants and neonates are particularly vulnerable to residual neuromuscular block due to developmental factors.

Purpose of the Study:

  • Identify common and preventable errors in pediatric neuromuscular block management.
  • Propose strategies to enhance perioperative safety for children.

Main Methods:

  • A narrative review synthesizing current evidence and clinical practices.
  • Analysis of recurrent pitfalls in neuromuscular blocking agent administration, monitoring, reversal, and postoperative care.

Main Results:

  • Four key error traps identified: improper agent use, lack of quantitative monitoring, incorrect reversal timing, and failure to address residual paralysis.
  • These errors lead to high rates of residual neuromuscular block and increased postoperative respiratory complications.
  • Pediatric-specific pharmacokinetic and pharmacodynamic variability exacerbates these risks.

Conclusions:

  • Systematic application of evidence-based practices is crucial for error avoidance.
  • Routine quantitative neuromuscular monitoring and achieving a train-of-four ratio ≥0.9 before extubation are essential.
  • Integrating these principles into practice is key to improving pediatric anesthesia safety.